Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

Description

This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk information may be used in future research related to breast cancer, other cancers, and women's health.

Conditions

Breast Carcinoma

Talk to us

Study Overview

On this page

Study Details

Study overview

This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk information may be used in future research related to breast cancer, other cancers, and women's health.

MERIT (Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies) Cohort

Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

Condition
Breast Carcinoma
Intervention / Treatment

-

Contacts and Locations

Houston

M D Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Willingness to participate in the study and ability to provide informed consent
  • * Willingness to complete a questionnaire and to provide a blood sample at the initial visit and at follow up annual visits
  • * Undergoing a screening mammogram at participating sites. Subjects undergoing routine annual diagnostic mammograms or CEM as part of a screening study are also eligible.
  • * Current or recent (within the prior 6 months) history of breast feeding
  • * Personal history of breast cancer (ductal breast carcinoma in situ \[DCIS\] or invasive breast cancer)
  • * Personal history of any other cancer (excluding in-situ, stage 0, and non-melanoma skin cancers and other pre-cancerous conditions) treated within the last 5 years.

Ages Eligible for Study

25 Years to 80 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

M.D. Anderson Cancer Center,

Jessica W Leung, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2025-04-30